share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144：擬議出售證券
美股sec公告 ·  06/06 22:41
牛牛AI助理已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 06/06/2024, with an aggregate market value of $450,000. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 406,319 shares were sold for gross proceeds of approximately $3.77 million.
Recursion Pharmaceuticals, Inc. officer and director Christopher Gibson is set to sell 50,000 Class A shares on 06/06/2024, with an aggregate market value of $450,000. The shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 406,319 shares were sold for gross proceeds of approximately $3.77 million.
Recursion Pharmaceuticals，Inc.董事兼高級執行官Christopher Gibson計劃於06/06/2024賣出50,000股A類股票，市值總額爲$450,000。這些股票最初於2016年9月1日作爲創始股份獲得，是發行人的一種補償形式。這一計劃的售出是在過去三個月一系列交易之後，總計售出了406,319股，總收益約爲$3.77 million。
Recursion Pharmaceuticals，Inc.董事兼高級執行官Christopher Gibson計劃於06/06/2024賣出50,000股A類股票，市值總額爲$450,000。這些股票最初於2016年9月1日作爲創始股份獲得，是發行人的一種補償形式。這一計劃的售出是在過去三個月一系列交易之後，總計售出了406,319股，總收益約爲$3.77 million。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。